Showing results (451-460 of 472) with videos related to
Sort By:
Pageof 48
Experimental Cell Research|December 15, 1996
The PML and PML/RARalpha domains: from autoimmunity to molecular oncology and from retinoic acid to arsenicC Andre, M C Guillemin, J Zhu, et al.Leukemia|June 26, 2015
Lithium chloride antileukemic activity in acute promyelocytic leukemia is GSK-3 and MEK/ERK dependentF Zassadowski, K Pokorna, N Ferre, et al.Blood|March 1, 1981
Surface antigens on malignant Sézary and T-CLL cells correspond to those of mature T cellsL Boumsell, A Bernard, E L Reinherz, et al.Leukemia & Lymphoma|December 28, 1999
Five years follow-up after 2-chloro deoxyadenosine treatment in thirty patients with hairy cell leukemia: evaluation of minimal residual disease and CD4+ lymphocytopenia after treatmentJ N Bastie, D Cazals-Hatem, M T Daniel, et al.Nutricion Hospitalaria|October 1, 1989
[The role of glucose-1-phosphate in total parenteral nutrition protocols]N V Jiménez Torres, J J Colomer, C L Ronchera Oms, et al.Rheumatology (Oxford, England)|April 20, 2006
Association between increased CCL2 (MCP-1) expression in lesions and persistence of disease activity in giant-cell arteritisM C Cid, M P Hoffman, J Hernández-Rodríguez, et al.Journal of Pediatric Surgery|April 6, 2017
Percutaneous ultrasound-guided vs. intraoperative rectus sheath block for pediatric umbilical hernia repair: A randomized clinical trialCristen N Litz, Sandra M Farach, Allison M Fernandez, et al.Cancer Epidemiology|June 26, 2018
Anxiety and depression in women with breast cancer: Social and clinical determinants and influence of the social network and social support (DAMA cohort)R Puigpinós-Riera, A Graells-Sans, G Serral, et al.Leukemia|August 15, 2000
Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia. European APL groupP Fenaux, S Chevret, A Guerci, et al.Blood|October 9, 1998
Incidence, clinical features, and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. The European APL GroupS De Botton, H Dombret, M Sanz, et al.Pageof 48